Be Pharma

Be Pharma

Hemophilia B, (NCT06611436)
Sponsors:
Be Biopharma
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Haemophilia B, (NCT06611436)
Sponsors:
Be Biopharma
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine